BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ansari I, Chaturvedi A, Chitkara D, Singh S. CRISPR/Cas mediated epigenome editing for cancer therapy. Semin Cancer Biol 2021:S1044-579X(20)30278-9. [PMID: 33421620 DOI: 10.1016/j.semcancer.2020.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kaplun DS, Kaluzhny DN, Prokhortchouk EB, Zhenilo SV. DNA Methylation: Genomewide Distribution, Regulatory Mechanism and Therapy Target. Acta Naturae 2022;14:4-19. [PMID: 36694897 DOI: 10.32607/actanaturae.11822] [Reference Citation Analysis]
2 Ahmad A. Special Issue: Epigenetic regulation of cancer progression: Promises and progress. Semin Cancer Biol 2021:S1044-579X(21)00298-4. [PMID: 34921992 DOI: 10.1016/j.semcancer.2021.12.005] [Reference Citation Analysis]
3 Mondal A, Bhattacharya A, Singh V, Pandita S, Bacolla A, Pandita RK, Tainer JA, Ramos KS, Pandita TK, Das C. Stress responses as master keys to epigenomic changes in transcriptome and metabolome for cancer etiology and therapeutics. Mol Cell Biol 2021;:MCB0048321. [PMID: 34748401 DOI: 10.1128/MCB.00483-21] [Reference Citation Analysis]
4 Alves E, Taifour S, Dolcetti R, Chee J, Nowak AK, Gaudieri S, Blancafort P. Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing. Mol Ther Methods Clin Dev 2021;21:592-606. [PMID: 34095343 DOI: 10.1016/j.omtm.2021.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]